Penn Med’s cancer center partners on immunology research

Penn Medicine’s Abramson Cancer Center and the Parker Institute for Cancer Immunotherapy have renewed their partnership to advance cancer immunotherapy research.

Advertisement

The renewal follows the Parker Institute announcing a $125 million investment across its network to expand research efforts, according to an Aug. 21 system news release. Penn has been part of the network since  its launch in 2016. The collaboration supports laboratory studies, clinical trials that study cancer immunology and training for early-career scientists.

The Parker Institute’s network includes hundreds of cancer researchers and seven cancer institutions. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.